IVIg Controls Dermatomyositis in Phase 3 Trial medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
In collaborative international effort, laser physicists at LMU have built the first hybrid plasma accelerator.
Particle accelerators have made crucial contributions to some of the most spectacular scientific discoveries of modern times, and greatly augmented our knowledge of the structure of matter. Now a team of laser physicists led by Prof. Stefan Karsch at the Ludwig-Maximilian University (LMU) in Munich and the Max Planck Institute for Quantum Optics, in cooperation with scientists based at the Helmholtz Centre in Dresden-Rossendorf (HZDR), the Laboratoire d Optique Appliquée in Paris (LOA), Strathclyde University in Glasgow and the DESY Electron Synchrotron in Hamburg, have now achieved a significant breakthrough in accelerator miniaturization. They have built the first compact two-stage plasma-based accelerator in which particles in a plasma wave initiated by a powerful laser are used to accelerate a beam of electrons.
Childhood brain tumors are thankfully rare but, despite all the progress made over recent years, they are often associated with poor prognoses and low survival rates.
Jun 01 2021
Childhood brain tumors are rare but, despite all the progress made over recent years, they are often associated with poor prognoses and low survival rates. Researchers at the Ludwig Maximilian University of Munich are focused on the rapid translation of drugs for use in this field, and the INTEGRA family of products – including VOYAGER adjustable tip spacing pipettes, the ASSIST PLUS pipetting robot, EVOLVE manual pipettes and PIPETBOY acu 2 pipette controllers – have been a part of the lab since its inception. Dr Alexander Beck, the head of the laboratory, explained: “We assess drugs in terms of their efficacy on tumor cells, blood-brain barrier penetration, toxicity and, on a deeper level, the tumor biology.”